STEVENS CAPITAL MANAGEMENT LP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$90,000
-3.2%
17,082
+44.5%
0.00%0.0%
Q4 2015$93,000
-64.5%
11,819
-61.9%
0.00%
-66.7%
Q3 2015$262,000
+43.2%
31,039
+85.2%
0.01%
+71.4%
Q2 2015$183,000
-47.1%
16,756
-18.3%
0.01%
-41.7%
Q4 2014$346,000
+109.7%
20,502
+48.1%
0.01%
+200.0%
Q1 2014$165,000
-34.8%
13,841
-24.5%
0.00%
-42.9%
Q4 2013$253,00018,3440.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
BVF INC/IL 15,232,268$41,279,0003.63%
NORTHPOINTE CAPITAL LLC 528,739$1,433,0000.21%
Opaleye Management Inc. 275,000$745,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 364,401$988,0000.12%
EcoR1 Capital, LLC 462,068$1,252,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 990,748$2,685,0000.08%
GSA CAPITAL PARTNERS LLP 284,354$771,0000.04%
Fosun International Ltd 358,859$879,0000.04%
Clear Harbor Asset Management, LLC 97,630$200,0000.04%
180 WEALTH ADVISORS, LLC 30,000$81,0000.04%
View complete list of INFINITY PHARMACEUTICALS INC shareholders